首页> 外文OA文献 >Pretransplant Immunosuppression followed by Reduced-Toxicity Conditioning and Stem Cell Transplantation in High-Risk Thalassemia: A Safe Approach to Disease Control

【2h】

Pretransplant Immunosuppression followed by Reduced-Toxicity Conditioning and Stem Cell Transplantation in High-Risk Thalassemia: A Safe Approach to Disease Control

机译：高风险地中海贫血患者的移植前免疫抑制，降低毒性条件和干细胞移植：一种安全的疾病控制方法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Anurathapan Usanarat; Pakakasama Samart; Rujkijyanont Piya; Sirachainan Nongnuch; Songdej Duantida; Chuansumrit Ampaiwan; Sirireung Somtawin; Charoenkwan Pimlak; Jetsrisuparb Arunee; Issaragrisil Surapol; Ungkanont Artit; Sruamsiri Rosarin; Srisala Supanart; Andersson Borje S.; Hongeng Suradej;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Pretransplant Immunosuppression followed by Reduced-Toxicity Conditioning and Stem Cell Transplantation in High-Risk Thalassemia: A Safe Approach to Disease Control [J] . AnurathapanU., PakakasamaS., RujkijyanontP., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2013,第8期

机译：高风险地中海贫血患者的移植前免疫抑制，毒性降低和干细胞移植：疾病控制的安全方法
2. Haploidentical Hematopoietic Stem Cell Transplantation (Haplo-SCT) with Pre-Transplant Immunosuppression and Post-Transplant Cyclophosphamide (Post-Cy) in Severe Thalassemia: A Novel Approach Transplant for Nonmalignant Diseases [J] . Hongeng Suradej, Pakakasama Samart, Anurathapan Usanarat, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第2Suppla1期

机译：重度地中海贫血患者的单倍型造血干细胞移植（Haplo-SCT）和移植前免疫抑制和移植后环磷酰胺（Cy后）：一种用于非恶性疾病的新型移植方法
3. The efficacy and safety of a new reduced-toxicity conditioning with 4 days of once-daily 100mg/m(2) intravenous busulfan associated with fludarabine and antithymocyte globulins prior to allogeneic stem cell transplantation in patients with high-risk myelodysplastic syndrome or acute leukemia [J] . Wanquet Anne, Crocchiolo Roberto, Furst Sabine, Leukemia and lymphoma . 2016,第10期

机译：异基因干细胞移植前高风险骨髓增生异常综合征或急性白血病患者每天进行一次为期4天，每天一次100mg / m（2）静脉白消安联合氟达拉滨和抗胸腺细胞球蛋白治疗的新型低毒治疗的安全性
4. Intense immunosuppression and stem cell transplantation in severe autoimmune diseases [C] . Lisukov, I.A. . 2000

机译：严重自身免疫疾病中的强免疫抑制和干细胞移植
5. Natural killer and T-cell immunity pretransplant as a predictor for cytomegalovirus post-transplant. [D] . Keshwani, Shanil S. 2015

机译：移植前自然杀手和T细胞免疫力可作为巨细胞病毒移植的预测因子。
6. Pharmacologic Immunoablation Followed by Reduced-Toxicity Conditioning and Stem Cell Transplantation in High-Risk Thalassemia: A Safe Approach to Disease Control [O] . Usanarat Anurathapan, Samart Pakakasama, Piya Rujkijyanont, -1

机译：药理学免疫消融继而在高危地中海贫血症中降低毒性并进行干细胞移植：一种安全的疾病控制方法
7. Pretransplant Immunosuppression Followed By Reduced Toxicity Conditioning and Stem Cell Transplantation in High Risk Thalassemia [O] . Hongeng Suradej, Pakakasama Samart, Anurathapan Usanarat, 2014

机译：高风险地中海贫血患者移植前免疫抑制后毒性反应和干细胞移植降低

Pretransplant Immunosuppression followed by Reduced-Toxicity Conditioning and Stem Cell Transplantation in High-Risk Thalassemia: A Safe Approach to Disease Control

著录项

引文网络

相似文献

相关主题

期刊订阅